MicroRNA-365 inhibits the proliferation of vascular smooth muscle cells by targeting cyclin D1

Journal of Cellular Biochemistry

Volumn 115, Issue 10, 2014, Pages 1752-1761

  Kim, Myung Hyun ^a   Ham, Onju ^b   Lee, Se Yeon ^b   Choi, Eunmi ^b   Lee, Chang Youn ^c   Park, Jun Hee ^c   Lee, Jiyun ^b   Seo, Hyang Hee ^b   Seung, Minji ^b   Choi, Eunhyun ^d   Min, Pil Ki ^a   Hwang, Ki Chul ^b  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Yonsei University   (South Korea)

^d Yonsei University College of Medicine   (South Korea)

Author keywords

CELL CYCLE; CYCLIN D1; MIR 365; PROLIFERATION; VASCULAR SMOOTH MUSCLE CELLS

Indexed keywords

ANGIOTENSIN II; CYCLIN D1; CYCLINE; MICRORNA; MICRORNA 365; PLATELET DERIVED GROWTH FACTOR BB; UNCLASSIFIED DRUG; MIRN365 MICRORNA, RAT; PLATELET DERIVED GROWTH FACTOR B; PLATELET-DERIVED GROWTH FACTOR BB; PROTEIN BINDING; RNA BINDING PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BINDING SITE; BLOOD VESSEL WALL; CAROTID ARTERY INJURY; CELL PROLIFERATION; DOWN REGULATION; G1 PHASE CELL CYCLE CHECKPOINT; GENE OVEREXPRESSION; LUCIFERASE ASSAY; NEOINTIMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RAT; REAL TIME POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING; ANIMAL; ATHEROSCLEROSIS; BIOSYNTHESIS; CAROTID ARTERY; CELL CULTURE; CELL DIVISION; CELL MOTION; CYTOLOGY; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; PATHOLOGY; S PHASE CELL CYCLE CHECKPOINT;

ANGIOTENSIN II; ANIMALS; ATHEROSCLEROSIS; CAROTID ARTERIES; CAROTID ARTERY INJURIES; CELL DIVISION; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CYCLIN D1; DOWN-REGULATION; MICRORNAS; MUSCLE, SMOOTH, VASCULAR; NEOINTIMA; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-SIS; RATS; RNA-BINDING PROTEINS; S PHASE CELL CYCLE CHECKPOINTS;

EID: 84906084431     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24841     Document Type: Article

References (32)

1. Ambros V,. 2004. The functions of animal microRNAs. Nature 431: 350-355.
2. Bartel DP,. 2009. MicroRNAs: target recognition and regulatory functions. Cell 136: 215-233.
3. Cai Y, Knight WE, Guo S, Li JD, Knight PA, Yan C,. 2012. Vinpocetine suppresses pathological vascular remodeling by inhibiting vascular smooth muscle cell proliferation and migration. J Pharmacol Exp Ther 343: 479-488.
4. Chen J, Yin H, Jiang Y, Radhakrishnan SK, Huang ZP, Li J, Shi Z, Kilsdonk EP, Gui Y, Wang DZ, Zheng XL,. 2011. Induction of microRNA-1 by myocardin in smooth muscle cells inhibits cell proliferation. Arterioscler Thromb Vasc Biol 31: 368-375.
5. Cordes KR, Sheehy NT, White MP, Berry EC, Morton SU, Muth AN, Lee TH, Miano JM, Ivey KN, Srivastava D,. 2009. MiR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 460: 705-710.
6. Diehl JA,. 2002. Cycling to cancer with cyclin D1. Cancer Biol Ther 1: 226-231.
7. Duan J, Huang H, Lv X, Wang H, Tang Z, Sun H, Li Q, Ai J, Tan R, Liu Y, Chen M, Duan W, Wei Y, Zhou Q,. 2012. PKHD1 post-transcriptionally modulated by miR-365-1 inhibits cell-cell adhesion. Cell Biochem Funct 30: 382-389.
8. Ferguson 3rd JE, Patterson C,. 2003. Break the cycle: the role of cell-cycle modulation in the prevention of vasculoproliferative diseases. Cell Cycle 2: 211-219.
9. Findeisen HM, Gizard F, Zhao Y, Qing H, Heywood EB, Jones KL, Cohn D, Bruemmer D,. 2011. Epigenetic regulation of vascular smooth muscle cell proliferation and neointima formation by histone deacetylase inhibition. Arterioscler Thromb Vasc Biol 31: 851-860.
10. Guan YJ, Yang X, Wei L, Chen Q,. 2011. MiR-365: a mechanosensitive microRNA stimulates chondrocyte differentiation through targeting histone deacetylase 4. FASEB J 25: 4457-4466.
11. Hwang HW, Mendell JT,. 2006. MicroRNAs in cell proliferation, cell death, and tumorigenesis. Br J Cancer 94: 776-780.
12. Ji R, Cheng Y, Yue J, Yang J, Liu X, Chen H, Dean DB, Zhang C,. 2007. MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation. Circ Res 100: 1579-1588.
13. Kang H, Hata A,. 2012. MicroRNA regulation of smooth muscle gene expression and phenotype. Curr Opin Hematol 19: 224-231.
14. Kang SM, Lee HJ, Cho JY,. 2013. MicroRNA-365 regulates NKX2-1, a key mediator of lung cancer. Cancer Lett 335: 487-494.
15. Karpurapu M, Wang D, Van Quyen D, Kim TK, Kundumani-Sridharan V, Pulusani S, Rao GN,. 2010. Cyclin D1 is a bona fide target gene of NFATc1 and is sufficient in the mediation of injury-induced vascular wall remodeling. J Biol Chem 285: 3510-3523.
16. Kim JS, Kim IK, Lee SY, Song BW, Cha MJ, Song H, Choi E, Lim S, Ham O, Jang Y, Hwang KC,. 2102. Anti-proliferative effect of rosiglitazone on angiotensin II-induced vascular smooth muscle cell proliferation is mediated by the mTOR pathway. Cell Biol Int 36: 305-310.
17. Li P, Zhu N, Yi B, Wang N, Chen M, You X, Zhao X, Solomides CC, Qin Y, Sun J,. 2013. MicroRNA-663 regulates human vascular smooth muscle cell phenotypic switch and vascular neointimal formation. Circ Res 113: 1117-1127.
18. Liu MW, Roubin GS, King 3rd. SB. 2011. Restenosis after coronary angioplasty. Potential biologic determinants and role of intimal hyperplasia. Circulation 79: 1374-1387.
19. Liu X, Cheng Y, Zhang S, Lin Y, Yang J, Zhang C,. 2009. Necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia. Circ Res 104: 476-487.
20. Liu XJ, Cheng YH, Chen XW, Yang J, Xu L, Zhang CX,. 2011. MicroRNA-31 regulated by the extracellular regulated kinase is involved in vascular smooth muscle cell growth via large tumor suppressor homolog 2. J Biol Chem 286: 42371-42380.
21. Marx SO, Totary-Jain H, Marks AR,. 2011. Vascular smooth muscle cell proliferation in restenosis. Circ Cardiovasc Interv 4: 104-111.
22. Merlet E, Atassi F, Motiani RK, Mougenot N, Jacquet A, Nadaud S, Capiod T, Trebak M, Lompré AM, Marchand A,. 2013. MiR-424/322 regulates vascular smooth muscle cell phenotype and neointimal formation in the rat. Cardiovasc Res 98: 458-468.
23. Nie J, Liu L, Zheng W, Chen L, Wu X, Xu Y, Du X, Han W,. 2012. MicroRNA-365, down-regulated in colon cancer, inhibits cell cycle progression and promotes apoptosis of colon cancer cells by probably targeting Cyclin D1 and Bcl-2. Carcinogenesis 33: 220-225.
24. Park ES, Lee KP, Jung SH, Lee DY, Won KJ, Yun YP, Kim B,. 2013. Compound K, an intestinal metabolite of ginsenosides, inhibits PDGF-BB-induced VSMC proliferation and migration through G1 arrest and attenuates neointimal hyperplasia after arterial injury. Atherosclerosis 228: 53-60.
25. Parmacek MS,. 2009. MicroRNA-modulated targeting of vascular smooth muscle cells. J Clin Invest 119: 2526-2528.
26. Qin B, Xiao B, Liang D, Xia J, Li Y, Yang H,. 2011. MicroRNAs expression in ox-LDL treated HUVECs: MiR-365 modulates apoptosis and Bcl-2 expression. Biochem Biophys Res Commun 410: 127-133.
27. Rangrez AY, Massy ZA, Metzinger-Le Meuth V, Metzinger L,. 2011. MiR-143 and miR-145: molecular keys to switch the phenotype of vascular smooth muscle cells. Circ Cardiovasc Genet 4: 197-205.
28. Ross R,. 1993. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362: 801-809.
29. Sarkar K, Sharma SK, Sachdeva R, Romeo F, Garza L, Mehta JL,. 2006. Coronary artery restenosis: vascular biology and emerging therapeutic strategies. Expert Rev Cardiovasc Ther 24: 543-556.
30. Torella D, Iaconetti C, Catalucci D, Ellison GM, Leone A, Waring CD, Bochicchio A, Vicinanza C, Aquila I, Curcio A, dorelli G, Indolfi C,. 2011. MicroRNA-133 controls vascular smooth muscle cell phenotypic switch in vitro and vascular remodeling in vivo. Circ Res 109: 880-893.
31. Tulis DA,. 2007. Rat carotid artery balloon injury model. Methods Mol Med 139: 1-30.
32. Wang YS, Wang HY, Liao YC, Tsai PC, Chen KC, Cheng HY, Lin RT, Juo SH,. 2012. MicroRNA-195 regulates vascular smooth muscle cell phenotype and prevents neointimal formation. Cardiovasc Res 95: 517-526.